Understanding Equine Monocytic Ehrlichiosis

Understanding Equine Monocytic Ehrlichiosis

The disease usually occurs near rivers, lakes, and wet pastures from mid- to late-summer.

Photo: Photos.com

Equine monocytic ehrlichiosi (EME) is also known as Potomac horse fever (PHF) and equine ehrlichial colitis. The disease has since been reported in most states in the United States, at least three Canadian provinces, and also in parts of South America, Europe, and India. The disease usually occurs near rivers, lakes, and wet pastures from mid- to late-summer.

The cause of EME is Neoricksettsia risticii, formerly Ehrlichia risticii. The reservoir for the causal agent is not clear but has been isolated from ticks, aquatic insects, flukes, and other helminths (parasitic worms). Snails act as an intermediate host in the fluke cycle. Horses are thought to be infected through the ingestion of insects, often mayflies, which may land in drinking water. Experimentally, the incubation period ranged from one to three weeks in horses.

In the early stage of the infection, horses might become anorexic, depressed, pyrexic (they have a fever), and have decreased gut sounds. This is usually followed by loose stools or watery diarrhea and colic. In the late stages of the disease, affected animals could have severe dehydration, ventral abdominal edema, and laminitis. Death is the consequence of cardiovascular compromise and toxemia. Case fatality rates range from 5 to 30%. Transplacental transmission is reported often leading to fetal resorption, abortion, or weak foals. Horse-to-horse transmission is not thought to occur.

Horses that recover from the disease could have protective immunity for up to two years. Available vaccines appear to have variable efficacy. Limiting proximity of horses to rivers, ponds, lakes, and low-lying pastures during the peak EME season and eliminating lighting at night in horse stables to minimize attraction of insects could reduce the risk of infection.

A provisional clinical diagnosis of EME needs to be confirmed by a veterinary laboratory competent in diagnosing the disease. A single positive indirect fluorescent antibody (or IFA) test result for EME on serum only indicates exposure to the agent. Paired blood samples collected two weeks apart demonstrating a four-fold or greater rise in titer is evidence of an active infection. In clinical cases, a polymerase chain reaction (PCR) assay should be performed on an EDTA blood sample as well as on a fecal sample, as presence of the causal organism in blood and feces might not temporally coincide. At necropsy, a scraping of the colonic mucosa is the specimen of choice for PCR testing for EME.

From January 2008 through August 2013, the University of Kentucky Veterinary Diagnostic Laboratory had 123 equine samples submitted that tested positive for EME by PCR. Included in this number were 26 horses submitted for necropsy that were diagnosed with EME. Of the necropsy cases, the sex distribution was 53% female and 47% male. The mean age distribution was 8.7 years (range 0.3 to 34 years). The breeds involved were mostly Thoroughbreds.

CONTACTS: Craig Carter, DVM, PhD, Dipl. ACVPM—859/257-8283—craig.carter@uky.edu
Jacqueline Smith, MS—jacqueline.smith2@uky.edu
Erdal Erol, DVM, MSc, PhD—erdal.erol@uky.edu
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, Ky.

This is an excerpt from Equine Disease Quarterly, funded by underwriters at Lloyd's, London, brokers, and their Kentucky agents.

About the Author

Equine Disease Quarterly

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More